FRE Fresenius SE & Co. KGaA
43.87EUR+0.53%Mkt Cap: 26.85B $P/E: 15.841d ago
Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients in North America, Europe, the Asia-Pacific, Latin America, and Africa. It operates through Fresenius Kabi and Fr…
Industry Peers
Medical Care FacilitiesKey Statistics
Company
Market Cap26.85B USD
Enterprise Value38.50B USD
Revenue (TTM)25.31B USD
Gross Profit6.19B USD
Net Income (TTM)1.37B USD
Revenue/Share41.33 EUR
Last Price43.87 EUR
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees178.5K
CountryDE
SectorHealthcare
IndustryMedical Care Facilities
ISINDE0005785604
Valuation
P/E (Trailing)15.84
P/E (Forward)11.03
PEG0.77
EV/EBITDA11.65
EV/Revenue1.52
P/S1.06
P/B1.25
EPS (TTM)2.77
EPS (Forward)3.95
52W Range
35.1149% of range52.96
52W High52.96 EUR
52W Low35.11 EUR
Profitability
Gross Margin24.89%
Oper. Margin10.63%
EBITDA Margin13.05%
Profit Margin5.53%
ROE6.62%
ROA3.05%
Growth
Revenue Growth5.20%
Earnings Growth17.20%
Cash Flow & Leverage
Operating CF2.80B USD
CapEx (TTM)1.63B USD
FCF Margin7.35%
FCF Yield6.92%
Net Debt11.02B USD
Net Debt/EBITDA3.34
Balance Sheet
Debt/Equity0.62
Current Ratio1.28
Quick Ratio0.65
Book Value/Sh34.98 EUR
Cash/Share2.27 EUR
Dividends
Fwd Div Rate1.05 EUR
Trail. Div Rate1.05 EUR
Div. Yield2.41%
5Y Avg Yield2.79%
Payout Ratio37.91%
Ex-Div DateMay 25, 2026
Pay Date—
Splits
Last Split3:1
Split DateAug 4, 2014
Analyst Consensus
Rating1.5 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)55.59 EUR
Upside (mean)+26.7%
Target Range50.00 EUR – 63.50 EUR
50.00+26.7% to mean63.50
# Analysts14
Ownership
Shares Out.563.24M
Float410.56M
Insiders27.00%
Institutions43.89%
Technical
SMA 5045.51 (-3.6%)
SMA 20044.49 (-1.4%)
Beta0.83
S&P 52W Chg14.58%
Avg Vol (30d)1.15M
Avg Vol (10d)1.11M
Technical Indicators
RSI (14)42.0
MACD-0.2581
MACD Signal-0.0133
MACD Hist.-0.2448
BB Upper46.97 EUR
BB Middle45.18 EUR
BB Lower43.39 EUR
BB Width7.92%
ATR (14)1.126 EUR
Vol Ratio (20d)0.59x